INCYTE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.51 USD | -1.58% |
|
+1.08% | -14.78% |
| May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
| May. 01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | -1.58% | +1.08% | -14.78% | -18.67% | -35.41% | 12.21B |  |  | |
- Stock Market
- Equities
- INCY Stock
- Charts Incyte Corporation
- Relative Strength Chart